News Legal Alert life sciences Publications
Wednesday March 16th, 2022
Sorry, this entry is only available in Polish.
Sorry, this entry is only available in Polish.
We have been recommended as one of the best law firms in 14 categories by The Legal500 EMEA 2024 ranking,…
On the website of the Government Legislation Centre on January 2 this year, a draft act amending the act on…
We are pleased to announce that the „International Advertising Law: A Practical Global Guide – Second Edition” has been published by…
On January 1, 2024, an amendment to the Public Health Act entered into force, revolutionizing the energy drinks market in…
General information CBD (cannabidiol) has been steadily gaining popularity for some years now, and the global CBD market is expected…
Nicotine pouches (which we wrote about in the report) are not covered by any specific regulations in Poland. In particular,…
DISTRIBUTION Possible ’faster’ export/sale of products included on the list of products facing potential shortages in Poland. The Main Pharmaceutical Inspectorate (GIF) will be able…
SK&S’ transaction team advised Velocity Clinical Research Inc.—the leading multi-specialty clinical sites business, in the acquisition of its first site…
“SK&S’ transaction team has advised AniCura AB in the acquisition process of veterinary clinic “Gliwcka Przychodnia Weterynaryjna”. One of the…
The Intellectual Property law team of Sołtysiński Kawecki & Szlęzak has been awarded a Gold Laurel in Intellectual Asset Management…
We are pleased to announce that the “Chambers Patent Litigation 2022 Global Practice Guide” has been published by Chambers and…
RESTRICTIONS ON TRADE Adding more products to the anti-export list (the requirement to report export to the Chief Pharmaceutical Inspectorate (GIF) 30 days…
During a January meeting of the Parliamentary Committee on Economy and Development,[1] the President of the Office of Competition and…
We are pleased to inform that veterinary clinic “Wróblewscy” located in Dąbrowa Górnicza has joined AniCura, a family of leading…
SK&S’ transaction team advised Velocity Clinical Research Inc.—the leading multi-specialty clinical sites business, in the acquisition of KO-MED Clinical Centers—one…